Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06563310 · ClinicalTrials.gov registry record · NA

Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4

A NA study of Anxiety and Generalized Anxiety Disorder, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT06563310: Recruiting NA study of Anxiety and Generalized Anxiety Disorder, sponsored by University of Michigan.

NCT06563310 is a NA study of Anxiety and Generalized Anxiety Disorder that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 110 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06563310, a NA study of Anxiety and Generalized Anxiety Disorder, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

This study seeks to understand emotion regulation in those with young adults with anxiety using real-time functional magnetic resonance imaging neurofeedback, a tool that allows individuals to control brain activity. The goal of this project is to understand how receiving feedback about one's own brain activity relates to emotion regulation ability. This work will help the study team understand the brain areas involved in emotion regulation and could lay the groundwork to test if psychotherapy outcomes can be enhanced using neurofeedback. The study hypotheses include: * Participants receiving veritable-Neurofeedback (NF) will show a greater activation increases in the prefrontal cortex (PFC) compared to sham-NF * Participants receiving veritable-NF will show greater cognitive reappraisal (CR) ability compared to those receiving sham-NF * PFC activation will positively correlate with CR ability

Conditions Studied

Anxiety Generalized Anxiety Disorder Social Anxiety Disorder Panic Disorder

Interventions

  • OTHER Functional magnetic resonance imaging (fMRI) with Veritable-NF
  • OTHER fMRI with Sham-NF

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2025-01-09
Est. Completion 2029-05
Phase NA
University of Michigan

1,327 total trials

What NCT06563310 shows while recruiting

NCT06563310 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower).

The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Functional magnetic resonance imaging (fMRI) with Veritable-NF is the first listed.

NCT06563310 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06563310 about?

NCT06563310 is a clinical study titled "Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4". This study seeks to understand emotion regulation in those with young adults with anxiety using real-time functional magnetic resonance imaging neurofeedback, a tool that allows individuals to control brain activity. The goal of this project is to understand how receiving feedback about one's own br...

What is the current status of trial NCT06563310?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2025-01-09. Estimated completion is 2029-05.

What conditions does trial NCT06563310 study?

This clinical trial studies the following conditions: Anxiety, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder.

What interventions are being tested in trial NCT06563310?

The interventions under investigation include: Functional magnetic resonance imaging (fMRI) with Veritable-NF (OTHER), fMRI with Sham-NF (OTHER).

Who is sponsoring clinical trial NCT06563310?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06563310 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06563310's enrollment target sits among peer trials

110 152nd of 364 higher than 211 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06563310

Source: ClinicalTrials.gov NCT06563310, the US trial registry maintained by the National Library of Medicine. NCT06563310 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.